ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Interview

Moderna plans to offer omicron-delta booster by fall: medical chief

U.S. vaccine developer sees need for annual shot as virus 'will not be eradicated'

Moderna will start a clinical trail for a next-generation booster against both the delta and omicron variants of the coronavirus.   © Reuters

NEW YORK -- Moderna will soon start a clinical trail for a next-generation booster that is effective against both the delta and omicron variants of the coronavirus, with the aim of delivering the shot this fall, the company's chief medical officer, Paul Burton, told Nikkei.

The vaccine developer is also planning to offer a shot that offers protection against both the seasonal flu and the coronavirus in 2023 as it sees COVID-19 as an endemic that humanity will have to grapple with for years to come.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more